CAS: 1935694-88-4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Spartalizumab REF: TM-T77075CAS: 1935694-88-4 | SDS-PAGE:95.2%;SEC-HPLC:96.3% | 172.00 €~851.00 € | Tue 10 Dec 24 |
 | Spartalizumab REF: 3D-CLA1490CAS: 1935694-88-4 | - - - | To inquire | Thu 19 Dec 24 |
Spartalizumab
CAS:1935694-88-4
"Spartalizumab (PDR001), a humanized IgG4 monoclonal antibody, targets PD-1 to inhibit PD-L1/L2 interactions, useful in …
Purity:
SDS-PAGE:95.2%;SEC-HPLC:96.3%
Color and Shape:
Liquid
Molecular weight:
145.74 kDa
Ref: TM-T77075
| 1mg | 172.00 € | ||
| 5mg | 502.00 € | ||
| 10mg | 851.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Spartalizumab
CAS:1935694-88-4
Monoclonal antibody targeting PD-1 (CD279), being researched for melanoma
Ref: 3D-CLA1490
| Undefined size | To inquire |
Estimated delivery in United States, on Thursday 19 Dec 2024
